PA Foundations in Industry Training Grant

Purpose: The goal of the Senate Bill 1 Sea Level Rise Adaptation Planning Grant Program (SB 1 Grant Program) is to support the implementation of SB 1 (Atkins, 2021) for local, regional, and tribal governments. Ultimately, the SB 1 Grant Program aims to provide funding for coastal communities to develop consistent sea level rise (SLR) adaptation plans and projects to build resilience to SLR along the entire coast of California and San Francisco Bay. Description: The SB 1 Grant Program aims to provide funding for sea level rise (SLR) adaptation planning to help prepare communities for the impacts of climate change. While many jurisdictions have advanced planning already underway or complete, many others have yet to begin comprehensive planning or assessments. The Ocean Protection Council (OPC) aims to address this need by offering funding for a range of SLR planning activities.

The Mini-Grant is designed to support business and nonprofit programs that serve the Erie County BIPOC community and are experiencing a need for an influx of capital to enable them to continue to serve the BIPOC community. Successful applicants will be able to show that either they or their project, is not eligible for traditional bank financing. The minimum grant offered is $5,000, and the maximum grant is $25,000. Applicants must be for-profit businesses located in Erie County, NY and at least 51% of the ownership is Black, Indigenous, or Person of Color (BIPOC).

The SF Shines Equipment Grant helps existing businesses purchase equipment essential to their operations. The goal is to support long-term success and help our City's commercial corridors thrive. Eligible businesses can receive up to $10,000 to buy equipment for their small business.

This program offers up to $10,000 in reimbursable financial support to West Virginia farmers, independent grocery stores, and producers who use locally grown products.

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.